46
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Tissue inhibitor of metalloproteinase‐1 levels in plasma from tumour arteries and veins of patients with rectal cancer

, , , &
Pages 545-552 | Received 06 Oct 2006, Accepted 11 Dec 2006, Published online: 08 Jul 2009
 

Abstract

Objective. Tissue inhibitor of metalloproteinase‐1 (TIMP‐1) plays a major role in the regulation of tissue growth, including cancer growth. The TIMP‐1 protein can be determined in plasma, and increased plasma levels of TIMP‐1 are associated with a poor prognosis of colorectal cancer patients. The aim of the present study was to evaluate whether tumour tissue release of the TIMP‐1 protein contributes to the increased plasma levels of TIMP‐1 observed in patients with colorectal cancer. Material and methods. Preoperative blood samples from a peripheral vein and intraoperative blood samples from a tumour artery, a tumour vein and from a peripheral vein were drawn from 24 patients undergoing elective, intended curative surgery for primary rectal cancer. TIMP‐1 levels were determined concurrently in plasma from all samples using a validated ELISA method. Counts of white blood cells and platelets were also carried out. Results. No significant differences between plasma TIMP‐1 levels could be demonstrated in any compartment. In particular, there was no significant difference in TIMP‐1 levels in plasma from tumour arteries and tumour veins. However, there was a significant decrease in neutrophil cell counts from tumour arteries to tumour veins (p<0.001). Conclusions. The present results do not support the current hypothesis that tumour cells contribute substantially to increased plasma TIMP‐1 levels observed in patients with colorectal cancer.

Acknowledgements

We thank Ms. Birgitte Sander Nielsen for skilful work with analysis of the soluble proteins. In addition, the staff of the Department of Surgical Gastroenterology of Hvidovre University Hospital is thanked for valuable support in the collection of intraoperative blood samples. The study was supported by grants from the Kornerup Fund, the Aage and Johanne Louis‐Hansen Fund, the Aase and Ejnar Danielsen Fund, the Walter and O. Kristiane Christensen Fund, the Jacob and Olga Madsen Fund, the Foundation for Improvement of Medical Science and the Danish Cancer Society.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.